[Tislelizumab as monotherapy or in combination with chemotherapy in locally advanced or metastatic non-small cell lung cancer]
Bull Cancer
.
2024 Nov 16:S0007-4551(24)00394-1.
doi: 10.1016/j.bulcan.2024.10.007.
Online ahead of print.
[Article in French]
Authors
Alexandre Olivier
1
,
Clémence Basse
2
Affiliations
1
Service de pneumologie, UFR santé de Caen, CHU de Caen, Caen, France. Electronic address: alexandre.f.olivier@gmail.com.
2
Institut du thorax Curie Montsouris, institut Curie, Paris, France.
PMID:
39551692
DOI:
10.1016/j.bulcan.2024.10.007
No abstract available
Keywords:
Cancer bronchique non à petites cellules; Non-small cell lung cancer; PD-1.
Publication types
Letter